Notebook

LEAVING HOWARD HUGHES After serving as the president of the Howard Hughes Medical Institute since 1987, Purnell W. Choppin has announced his resignation. "While my enthusiasm for the position I have been privileged to hold and my dedication to the Institute remain as intense as ever, I believe that it will be time for someone to take up the reins and lead HHMI into the new millennium," Choppin wrote in a letter to the institute's staff. He will remain in the position through 1999. Under Choppin

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

LEAVING HOWARD HUGHES After serving as the president of the Howard Hughes Medical Institute since 1987, Purnell W. Choppin has announced his resignation. "While my enthusiasm for the position I have been privileged to hold and my dedication to the Institute remain as intense as ever, I believe that it will be time for someone to take up the reins and lead HHMI into the new millennium," Choppin wrote in a letter to the institute's staff. He will remain in the position through 1999. Under Choppin's tenure, the institute's budget grew from $77 million to $556 million. Choppin also oversaw the construction of the Institute's campus headquarters and conference center in Chevy Chase, Md. Choppin came to HHMI in 1985 as vice president and chief scientific officer from Rockefeller University, where he was Leon Hess Professor of Virology, vice president for academic programs, and dean of graduate studies. He headed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies